Monterey Bio Acquisition Corporation

MTRY · NASDAQ
Analyze with AI
6/30/2023
3/31/2023
12/31/2022
9/30/2022
Operating Activities
Net Income-$151-$152-$307-$420
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$70$244$108$823
Other Non-Cash-$258-$224-$188-$524
Operating Cash Flow-$340-$133-$387-$121
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$115-$238$95,704$0
Investing Cash Flow-$115-$238$95,704$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0-$96$0
Dividends Paid$0$0$0$0
Other Fin. Act.$776$443-$95,716$361
Financing Cash Flow$776$443-$95,716$361
Forex Effect$0$0$0$299
Net Chg. in Cash$321$73-$398$539
Supplemental Information
Beg. Cash$218$146$544$5
End Cash$540$218$146$544
Free Cash Flow-$340-$133-$387-$121